A detailed history of Vanguard Group Inc transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 851,392 shares of THRD stock, worth $10.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
851,392
Previous 839,880 1.37%
Holding current value
$10.4 Million
Previous $9.21 Million 12.76%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$8.6 - $11.24 $99,003 - $129,394
11,512 Added 1.37%
851,392 $8.04 Million
Q4 2023

Feb 14, 2024

BUY
$5.97 - $11.47 $396,539 - $761,860
66,422 Added 8.59%
839,880 $9.21 Million
Q3 2023

Nov 14, 2023

BUY
$4.92 - $7.09 $17,785 - $25,630
3,615 Added 0.47%
773,458 $4.94 Million
Q2 2023

Aug 14, 2023

BUY
$4.18 - $5.33 $91,529 - $116,711
21,897 Added 2.93%
769,843 $3.7 Million
Q1 2023

May 15, 2023

BUY
$3.95 - $4.49 $203,725 - $231,576
51,576 Added 7.41%
747,946 $3.08 Million
Q4 2022

Feb 10, 2023

BUY
$4.0 - $22.0 $2.39 Million - $13.1 Million
596,370 Added 596.37%
696,370 $2.99 Million
Q3 2022

Nov 14, 2022

BUY
N/A
100,000 New
100,000 $1.9 Million

Others Institutions Holding THRD

About Third Harmonic Bio, Inc.


  • Ticker THRD
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,328,900
  • Market Cap $494M
More about THRD
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.